Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Diabetes Research"
DOI: 10.1155/2018/6470137
Abstract: Sodium-glucose cotransporter 2 inhibitor tofogliflozin is a new type of antidiabetic drug for individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to examine in which type of individuals and/or under…
read more here.
Keywords:
tofogliflozin;
composition glycemic;
body composition;
glycemic control ... See more keywords